Skip to main content
. 2017 Dec 18;2017:4532409. doi: 10.1155/2017/4532409

Table 1.

Clinical and demographic features of IgAN patients and healthy controls.

Feature pDC IFN-alpha
Healthy controls IgAN patients Healthy controls IgAN patients
Gender (male/female) 12/21 11/21 10/22 9/25
Age (yr) 33.6 ± 9.3 32.5 ± 9.7 35.8 ± 9.6 31.7 ± 9.3
Serum creatinine (μM) 81.3 ± 32.8 69 ± 24
24-hour proteinuria (g/24 h) 1.00 ± 0.78 0.74 ± 0.48
eGFR 98.5 ± 29.1 108.4 ± 23.9